Professional Documents
Culture Documents
Breast cancer is a malignant tumor that starts in the cells of the breast.
A malignant tumor is a group of cancer cells that can grow into (invade) surrounding tissues or spread (metastasize) to distant areas of the body.
The disease occurs almost entirely in women, but men can get it, too.
One of every 13 Filipino women are expected to develop breast cancer in her lifetime. (Philippine Star, 2013) Breast cancer is the most common cancer in the Philippines, taking at least 16 percent of the 50,000 cases diagnosed. (Department of Health and Philippine Cancer Society, 2010) In men , less than 1% of all breast cancers. (Dr. Aldine Basa, 2010)
Proto-oncogenes
responsible for promoting cell growth.
Proto-oncogenes (acquired)
they become oncogenes and then can promote tumor formation or growth.
Invasive Breast Cancer Infiltrating Ductal Carcinoma originates in the mammary glands and grows in the epithelial cells lining these ducts.
Manifestation of Metastases
Metastatic breast cancer to the lung or pleura causes
chronic cough, dyspnea abnormal chest X-ray chest pain
Manifestation of Metastases
Metastatic disease to the bone causes
severe, progressive pain less commonly pathological fracture erythema over the affected bone swelling
Manifestation of Metastases
Metastatic breast cancer to the brain causes the following symptoms:
persistent, progressively worsening headache, visual changes, seizures, nausea or vomiting, vertigo, behavioral and personality changes, increased intracranial pressure.
Manifestation of Metastases
Metastatic disease to the liver causes
Jaundice elevated liver enzymes abdominal pain loss of appetite nausea vomiting
Gender
Simply being a woman is the main risk factor for developing breast cancer. Men can develop breast cancer, but this disease is about 100 times more common among women than men. This is likely because men have less of the female hormones estrogen and progesterone, which can promote breast cancer cell growth
Aging
Your risk of developing breast cancer increases as you get older. About 1 out of 8 invasive breast cancers are found in women younger than 45, while about 2 of 3 invasive breast cancers are found in women age 55 or older.
Genetics
Inherited DNA changes can increase the risk for developing cancer and are responsible for the cancers. The BRCA1 and BRCA2 are Tumor Suppressor Genes that are inherited.
Proliferative lesions with atypia: In these conditions, there is an overgrowth of cells in the ducts or lobules of the breast tissue, with some of the cells no longer appearing normal. They have a stronger effect on breast cancer risk, raising it 3 1/2 to 5 times higher than normal.
Menstrual periods
Women who have had more menstrual cycles because they started menstruating early (before age 12) and/or went through menopause later (after age 55) have a slightly higher risk of breast cancer. The increase in risk may be due to a longer lifetime exposure to the hormones estrogen and progesterone.
Having children
Women who have had no children or who had their first child after age 30 have a slightly higher breast cancer risk.
Alcohol
Alcohol causes cancer cells' blood vessels to grow which in turn fuels the growth of the tumor, a process known as angiogenesis.
Tobacco Smoking
For a long time, studies found no link between cigarette smoking and breast cancer.
In 2009, the International Agency for Research on Cancer concluded that there is limited evidence that tobacco smoking causes breast cancer.
It is Suggestive but not Sufficient evidence of a link at this point. (The 2006 US Surgeon General's report, The Health Consequences of Involuntary Exposure to Tobacco Smoke)
Women age 40 and older should have a mammogram every year and should continue to do so for as long as they are in good health.
Women in their 20s and 30s should have a clinical breast exam (CBE) as part of a periodic (regular) health exam by a health professional preferably every 3 years. Starting at age 40, women should have a CBE by a health professional every year.
Breast self-examination (BSE) is an option for women starting in their 20s. Women should be told about the benefits and limitations of BSE. Women should report any breast changes to their health professional right away.
Women at high risk (greater than 20% lifetime risk) should get an MRI and a mammogram every year.
Nursing Diagnosis
Deficient knowledge related to planned surgical treatments. Anxiety related to the diagnosis of cancer Fear related to specific treatments and body image changes Risk for ineffective coping related to the diagnosis of breast cancer Decisional conflict related to treatment options. Disturbed body image related to loss or alteration of the breast
Screening Procedures
Self-Breast Examination Clinical Breast Examination Mammogram
Treatment
Lumpectomy Partial or segmental mastectomy Simple mastectomy Modified radical mastectomy Axillary lymph node dissection Chemotherapy Radiation Therapy
Nursing Interventions
Monitor for adverse effects of radiation therapy such as fatigue, sore throat, dry cough, nausea, anorexia. Monitor for adverse effects of chemotherapy; bone marrow suppression, nausea and vomiting, alopecia, weight gain or loss, fatigue, stomatitis, anxiety, and depression. Realize that a diagnosis of breast cancer is a devastating emotional shock to the woman. Provide psychological support to the patient throughout the diagnostic and treatment process. Involve the patient in planning and treatment.
Nursing Interventions
Describe surgical procedures to alleviate fear. Prepare the patient for the effects of chemotherapy, and plan ahead for alopecia, fatigue. Administer antiemetics prophylactically, as directed, for patients receiving chemotherapy. Administer I.V. fluids and hyperalimentation as indicated. Help patient identify and use support persons or family or community. Suggest to the patient the psychological interventions may be necessary for anxiety, depression, or sexual problems. Teach all women the recommended cancer-screening procedures.
Medications
Trastuzumab (Herceptin) Pertuzumab (Perjeta) Ado-trastuzumab emtansine (KadcylaLapatinib (Tykerb) Bevacizumab (Avastin)